REBOXETINE: 185 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
185
Total FAERS Reports
19 (10.3%)
Deaths Reported
63
Hospitalizations
185
As Primary/Secondary Suspect
23
Life-Threatening
6
Disabilities
First Report: 19980101 · Latest Report: 20230223
What Are the Most Common REBOXETINE Side Effects?
#1 Most Reported
Hyperhidrosis
21 reports (11.4%)
#2 Most Reported
Off label use
20 reports (10.8%)
#3 Most Reported
Weight increased
18 reports (9.7%)
All REBOXETINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperhidrosis | 21 | 11.4% | 0 | 0 |
| Off label use | 20 | 10.8% | 0 | 1 |
| Weight increased | 18 | 9.7% | 0 | 0 |
| Tachycardia | 17 | 9.2% | 2 | 2 |
| Confusional state | 16 | 8.7% | 2 | 9 |
| Intentional overdose | 16 | 8.7% | 2 | 10 |
| Nausea | 16 | 8.7% | 1 | 6 |
| Drug ineffective | 15 | 8.1% | 0 | 9 |
| Drug interaction | 15 | 8.1% | 0 | 5 |
| Sleep disorder | 15 | 8.1% | 0 | 3 |
| Alanine aminotransferase increased | 14 | 7.6% | 0 | 1 |
| Depression | 14 | 7.6% | 0 | 4 |
| Dizziness | 14 | 7.6% | 0 | 1 |
| Oedema peripheral | 14 | 7.6% | 0 | 0 |
| Therapeutic product effect incomplete | 14 | 7.6% | 0 | 0 |
| Anxiety | 13 | 7.0% | 1 | 4 |
| Abdominal pain upper | 12 | 6.5% | 0 | 4 |
| Constipation | 12 | 6.5% | 0 | 5 |
| Drug abuse | 12 | 6.5% | 1 | 8 |
| C-reactive protein increased | 11 | 6.0% | 0 | 0 |
Who Reports REBOXETINE Side Effects? Age & Gender Data
Gender: 62.7% female, 37.3% male. Average age: 53.6 years. Most reports from: AU. View detailed demographics →
Is REBOXETINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 2 | 1 | 0 |
| 2004 | 6 | 0 | 6 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 6 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 3 | 1 | 1 |
| 2013 | 6 | 2 | 3 |
| 2014 | 4 | 0 | 1 |
| 2015 | 2 | 0 | 0 |
| 2016 | 1 | 0 | 0 |
| 2017 | 5 | 0 | 3 |
| 2018 | 12 | 0 | 2 |
| 2019 | 14 | 0 | 7 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 0 |
| 2023 | 3 | 0 | 1 |
What Is REBOXETINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 64 |
| Depression | 62 |
| Bipolar disorder | 11 |
| Antidepressant therapy | 7 |
| Major depression | 6 |
| Schizophrenia | 6 |
| Drug abuse | 5 |
| Schizoaffective disorder | 5 |
REBOXETINE vs Alternatives: Which Is Safer?
REBOXETINE vs RECLAST
REBOXETINE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
REBOXETINE vs REGADENOSON
REBOXETINE vs REGORAFENIB
REBOXETINE vs REGORAFENIB\REGORAFENIB
REBOXETINE vs RELATLIMAB
REBOXETINE vs RELPAX
REBOXETINE vs RELUGOLIX
REBOXETINE vs REMDESIVIR
REBOXETINE vs REMERON
Official FDA Label for REBOXETINE
Official prescribing information from the FDA-approved drug label.